Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation-Reference-Cited by-同舟云学术

Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation

Published:2002-12-19 Issue:1 Volume:42 Page:53-60
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Pajor L,Kereskai L,Zsdrál K,Nagy Z,Vass J A,Jáksó P,Radványi G

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2559.2003.01516.x/fullpdf

Reference25 articles.

1. Essential thrombocythaemia: an interim report from the Polycythaemia Vera Study Group;Murphy;Semin. Hematol.,1986

2. Experience of the Polycythaemia Vera Study Group with essential thrombocythaemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment;Murphy;Semin. Hematol.,1997

3. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome;Stoll;Am. J. Hematol.,1988

4. Essential thrombocythaemia and the Philadelphia chromosome;Morris;Br. J. Haematol.,1988

5. Molecular analysis of Philadelphia positive essential thrombocythemia;Martiat;Leukemia,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Két myeloproliferativ betegség egy betegben – klónok együttélése és vetélkedése;Orvosi Hetilap;2022-07-10

2. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms;Annals of Hematology;2018-06-27

3. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated withJAK2V617F or calreticulin mutations;Journal of Clinical Pathology;2016-01-11

4. Essential Thrombocythemia (ET);Chronic Myeloid Neoplasias and Clonal Overlap Syndromes;2010

5. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36);Cancer Genetics and Cytogenetics;2008-04